Your browser doesn't support javascript.
loading
Dose recommendations for anticancer drugs in patients with renal or hepatic impairment.
Krens, Stefanie D; Lassche, Gerben; Jansman, Frank G A; Desar, Ingrid M E; Lankheet, Nienke A G; Burger, David M; van Herpen, Carla M L; van Erp, Nielka P.
Afiliación
  • Krens SD; Department of Clinical Pharmacy, Radboud University Medical Center, Nijmegen, Netherlands.
  • Lassche G; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
  • Jansman FGA; Department of Pharmacy, Deventer Hospital, Deventer, Netherlands; PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, Netherlands.
  • Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
  • Lankheet NAG; Department of Clinical Pharmacy, Radboud University Medical Center, Nijmegen, Netherlands; Department of Clinical Pharmacy, Medisch Spectrum Twente, Enschede, Netherlands.
  • Burger DM; Department of Clinical Pharmacy, Radboud University Medical Center, Nijmegen, Netherlands.
  • van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
  • van Erp NP; Department of Clinical Pharmacy, Radboud University Medical Center, Nijmegen, Netherlands. Electronic address: nielka.vanerp@radboudumc.nl.
Lancet Oncol ; 20(4): e200-e207, 2019 04.
Article en En | MEDLINE | ID: mdl-30942181

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Insuficiencia Hepática / Insuficiencia Renal / Neoplasias / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Insuficiencia Hepática / Insuficiencia Renal / Neoplasias / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos
...